Skip to content

Changes in ocular surface after treatment for Meibomian Gland Dysfunction

Changes in ocular surface after treatment for Meibomian Gland Dysfunction - Changes in ocular surface after treatment for Meibomian Gland Dysfunction

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000044091
Enrollment
60
Registered
2021-05-01
Start date
2020-09-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian Gland Dysfunction

Interventions

None listed

Sponsors

Toho University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with Meibomian Gland Dysfunction

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Ocular surface temperature and circulation, tear breakup time, subjective symptoms, Meibography

Countries

Japan

Contacts

Public ContactYuichi Hori

Toho University Omori Medical Center Ophthalmology

yhori@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026